Point-of-Care test for immunosuppressant drugs

免疫抑制剂药物的即时检测

• 批准号: nhmrc : 1113262
• 负责人: Prof Kirill Alexandrov
• 金额: $ 40.22万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Development Grants
• 财政年份: 2016
• 资助国家: 澳大利亚
• 起止时间: 2016-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/point-of-care-immunosuppressant-drugs/663243
• 关键词: Point; Care; test; immunosuppressant; drugs

Organ transplantation is the measure of last resort for patients with organ failure. While this is a life-saving procedure, the long-term survival of transplant recipients depends on maintaining the new organ without rejecting it. The proposed research will create novel test systems that allow both patients and clinicians to monitor the concentration of the drugs required to suppress organ rejection. Such a test will reduce the cost of treatment and increase the long term survival of patients.

器官移植是器官衰竭患者的最后手段。虽然这是一个挽救生命的过程，但移植受者的长期生存取决于维持新器官而不排斥它。这项拟议的研究将创建新的测试系统，允许患者和临床医生监控抑制器官排斥所需药物的浓度。这样的检测将降低治疗成本，提高患者的长期存活率。